Vimarsana
Biggest News Aggregation in the World

Jamesf Markmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jamesf Markmann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jamesf Markmann Today - Breaking & Trending Today

Promising alternative strategy for islet transplantation in people with type 1 diabetes - Vimarsana News

Promising alternative strategy for islet transplantation in people with type 1 diabetes

In people with type 1 diabetes, the body's immune system attacks and destroys insulin-producing β cells that control blood glucose levels and are part of a group of cells in the pancreas called pancreatic islets.

New Data, Film Highlight Islet Cell Transplantation Progress - Vimarsana News

New Data, Film Highlight Islet Cell Transplantation Progress

A new documentary, to be released June 24, shows the human side of islet cell transplantation research for type 1 diabetes and follows encouraging data presentations at two medical meetings.

Top in endocrinology: Stem cell-derived therapy for type 1 diabetes; surgical weight loss - Vimarsana News

Top in endocrinology: Stem cell-derived therapy for type 1 diabetes; surgical weight loss

Researchers at the American Diabetes Association Scientific Sessions reported that a patient with type 1 diabetes gained insulin independence after receiving an investigational stem cell-derived pancreatic islet cell therapy.

Source: healio.com
Stem Cell Transplants Promising So Far in Type 1 Diabetes - Vimarsana News

Stem Cell Transplants Promising So Far in Type 1 Diabetes

A second patient who received Vertex's VX-880 has experienced glycemic improvements, whereas the first one is completely insulin-independent.

First patient gains insulin independence with novel stem cell-derived islet cell therapy - Vimarsana News

First patient gains insulin independence with novel stem cell-derived islet cell therapy

NEW ORLEANS — A man with long-standing type 1 diabetes and no endogenous insulin production achieved insulin independence after an infusion of an investigational stem cell-derived pancreatic islet cell therapy, researchers reported.In a proof-of-concept study, treatment with half the target dose of VX-880 (Vertex Pharmaceuticals), a novel allogeneic stem cell-derived, fully differentiated,

Source: healio.com